Long-term Safety and Efficacy of GBG Study Participants
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGBG Forschungs GmbH
About this trial
The ETERNITY study is an international, multicenter, observational study that aims to follow up patients who have participated in a GBG trial for early breast cancer, even after the study has officially ended, in order to collect long-term data on survival, late or delayed adverse events, in addition to information related to pregnancy, fertility and other parameters impacting quality of life.
Eligibility criteria
Qualifiers
Participation and treatment in a GBG clinical trial for early breast cancer.
Prospective registration: Written informed consent according to local regulatory requirements prior to data and biomaterial collection.
Disqualifiers
Participation and treatment in a non-GBG clinical trial for early breast cancer.
Patients with advanced or metastatic breast cancer who have participated and received treatment in a GBG clinical trial.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov